{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:35Z","timestamp":1707524555313},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,16]]},"DOI":"10.7759\/cureus.25061","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T06:42:08Z","timestamp":1652769728000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-ST-Segment Elevation Myocardial Infarction Shortly After Starting Steroid Replacement Therapy in a Patient With Adrenal Insufficiency"],"prefix":"10.7759","author":[{"given":"Mustafa","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Majeed","family":"Maliyakkal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Oxford handbook of endocrinology and diabetes. 3-d edition","author":"Wass J","year":"2014","unstructured":"Wass J, Owen K, Helen T. Oxford handbook of endocrinology and diabetes. 3-d edition. Oxford Press, New York, NY; 2014."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei L","year":"2004","unstructured":"Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004, 141:764-70. 10.7326\/0003-4819-141-10-200411160-00007","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein PC","year":"2004","unstructured":"Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, Walker BR. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart. 2004, 90:859-65. 10.1136\/hrt.2003.020180","journal-title":"Heart"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.02.040","article-title":"Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review","volume":"78","author":"Ruyssen-Witrand A","year":"2011","unstructured":"Ruyssen-Witrand A, Fautrel B, Saraux A, Le Lo\u00ebt X, Pham T. Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint Bone Spine. 2011, 78:23-30. 10.1016\/j.jbspin.2010.02.040","journal-title":"Joint Bone Spine"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02298","article-title":"Sex-specific risk of cardiovascular disease in autoimmune Addison disease\u2014A population-based cohort study","volume":"104","author":"Skov J","year":"2019","unstructured":"Skov J, Sundstr\u00f6m A, Ludvigsson JF, K\u00e4mpe O, Bensing S. Sex-specific risk of cardiovascular disease in autoimmune Addison disease\u2014A population-based cohort study. J Clin Endocrinol Metab. 2019, 104:2031-40. 10.1210\/jc.2018-02298","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02571-3","article-title":"Cardiovascular outcome in patients with adrenal insufficiency-a therapeutic dilemma","volume":"72","author":"Rahvar AH","year":"2021","unstructured":"Rahvar AH, Riesel M, Graf T, Harbeck B. Cardiovascular outcome in patients with adrenal insufficiency-a therapeutic dilemma. Endocrine. 2021, 72:582-5. 10.1007\/s12020-020-02571-3","journal-title":"Endocrine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-12-8","article-title":"Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - A worldwide patient survey","volume":"12","author":"Forss M","year":"2012","unstructured":"Forss M, Batcheller G, Skrtic S, Johannsson G. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - A worldwide patient survey. BMC Endocr Disord. 2012, 12:8. 10.1186\/1472-6823-12-8","journal-title":"BMC Endocr Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society clinical practice guideline","volume":"101","author":"Bornstein SR","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, et al.. Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016, 101:364-89. 10.1210\/jc.2015-1710","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson H","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-H\u00e4ggstr\u00f6m M, Mattsson A, Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab. 2006, 91:3954-61. 10.1210\/jc.2006-0524","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1991.tb01906.x","article-title":"Pharmacokinetics and oral bioavailability of hydrocortisone","volume":"31","author":"Derendorf H","year":"1991","unstructured":"Derendorf H, M\u00f6llmann H, Barth J, M\u00f6llmann C, Tunn S, Krieg M. Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharmacol. 1991, 31:473-6. 10.1002\/j.1552-4604.1991.tb01906.x","journal-title":"J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04352.x","article-title":"A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency","volume":"77","author":"Ekman B","year":"2012","unstructured":"Ekman B, Bachrach-Lindstr\u00f6m M, Lindstr\u00f6m T, Wahlberg J, Blomgren J, Arnqvist HJ. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency. Clin Endocrinol (Oxf). 2012, 77:18-25. 10.1111\/j.1365-2265.2012.04352.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03596.x","article-title":"Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency","volume":"72","author":"Bleicken B","year":"2010","unstructured":"Bleicken B, Hahner S, Loeffler M, Ventz M, Decker O, Allolio B, Quinkler M. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin Endocrinol (Oxf). 2010, 72:297-304. 10.1111\/j.1365-2265.2009.03596.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0681-z","article-title":"Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease","volume":"51","author":"Giordano R","year":"2016","unstructured":"Giordano R, Guaraldi F, Marinazzo E, et al.. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease. Endocrine. 2016, 51:360-8. 10.1007\/s12020-015-0681-z","journal-title":"Endocrine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-865772","article-title":"High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarism","volume":"113","author":"Krzyzanowska K","year":"2005","unstructured":"Krzyzanowska K, Schnack C, Mittermayer F, Kopp HP, Hofer M, Kann T, Schernthaner G. High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarism. Exp Clin Endocrinol Diabetes. 2005, 113:430-4. 10.1055\/s-2005-865772","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2005.07.004","article-title":"Cerebrovascular disease in patients with pituitary tumors","volume":"16","author":"Erfurth EM","year":"2005","unstructured":"Erfurth EM, Hagmar L. Cerebrovascular disease in patients with pituitary tumors. Trends Endocrinol Metab. 2005, 16:334-42. 10.1016\/j.tem.2005.07.004","journal-title":"Trends Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0874","article-title":"Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy","volume":"160","author":"Debono M","year":"2009","unstructured":"Debono M, Ross RJ, Newell-Price J. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol. 2009, 160:719-29. 10.1530\/EJE-08-0874","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/EC-16-0081","article-title":"Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency","volume":"6","author":"Quinkler M","year":"2017","unstructured":"Quinkler M, Ekman B, Marelli C, Uddin S, Zelissen P, Murray RD. Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency. Endocr Connect. 2017, 6:1-8. 10.1530\/EC-16-0081","journal-title":"Endocr Connect"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4305Adrenal","article-title":"Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency","volume":"99","author":"Petersons CJ","year":"2014","unstructured":"Petersons CJ, Mangelsdorf BL, Thompson CH, Burt MG. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency. J Clin Endocrinol Metab. 2014, 99:2269-76. 10.1210\/jc.2013-4305Adrenal","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","article-title":"Adrenal insufficiency in acute coronary syndrome","volume":"50","author":"Norasyikin AW","year":"2009","unstructured":"Norasyikin AW, Norlela S, Rozita M, Masliza M, Shamsul AS, Nor Azmi K. Adrenal insufficiency in acute coronary syndrome. Singapore Med J. 2009, 50:962-6.","journal-title":"Singapore Med J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2001.tb00202.x","article-title":"Adrenal insufficiency in critically ill emergency department patients: a Taiwan preliminary study","volume":"8","author":"Chang SS","year":"2001","unstructured":"Chang SS, Liaw SJ, Bullard MJ, Chiu TF, Chen JC, Liao HC. Adrenal insufficiency in critically ill emergency department patients: a Taiwan preliminary study. Acad Emerg Med. 2001, 8:761-4. 10.1111\/j.1553-2712.2001.tb00202.x","journal-title":"Acad Emerg Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4970858","article-title":"Dexamethasone associated ST Elevation Myocardial infarction four days after an unremarkable coronary angiogram-another reason for cautious use of steroids: a case report and review of the literature","volume":"2016","author":"Shokr M","year":"2016","unstructured":"Shokr M, Rashed A, Lata K, Kondur A. Dexamethasone associated ST Elevation Myocardial infarction four days after an unremarkable coronary angiogram-another reason for cautious use of steroids: a case report and review of the literature. Case Rep Cardiol. 2016, 2016:4970858. 10.1155\/2016\/4970858","journal-title":"Case Rep Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2014.02.016","article-title":"Steroid-induced recurrent myocardial ischemia","volume":"33","author":"Yildirim U","year":"2014","unstructured":"Yildirim U, Gulel O, Soylu K, Yuksel S, Sahin M. Steroid-induced recurrent myocardial ischemia. Rev Port Cardiol. 2014, 33:473.e1-4. 10.1016\/j.repc.2014.02.016","journal-title":"Rev Port Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5830\/CVJA-2013-013","article-title":"Acute myocardial infarction after prednisolone administration for the treatment of anaphylaxis caused by a wasp sting","volume":"24","author":"Arslan Z","year":"2013","unstructured":"Arslan Z, Iyisoy A, Tavlasoglu M. Acute myocardial infarction after prednisolone administration for the treatment of anaphylaxis caused by a wasp sting. Cardiovasc J Afr. 2013, 24:e4-6. 10.5830\/CVJA-2013-013","journal-title":"Cardiovasc J Afr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.53.1008","article-title":"Three cases of vasospastic angina that developed following the initiation of corticosteroid therapy","volume":"53","author":"Okumura W","year":"2014","unstructured":"Okumura W, Nakajima M, Tateno R, Fukuda N, Kurabayashi M. Three cases of vasospastic angina that developed following the initiation of corticosteroid therapy. Intern Med. 2014, 53:221-5. 10.2169\/internalmedicine.53.1008","journal-title":"Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00364.2002","article-title":"Inhibitory effect of glucocorticoid on coronary artery endothelial function","volume":"283","author":"Rogers KM","year":"2002","unstructured":"Rogers KM, Bonar CA, Estrella JL, Yang S. Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am J Physiol Heart Circ Physiol. 2002, 283:H1922-8. 10.1152\/ajpheart.00364.2002","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/81391-non-st-segment-elevation-myocardial-infarction-shortly-after-starting-steroid-replacement-therapy-in-a-patient-with-adrenal-insufficiency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:49Z","timestamp":1707507589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/81391-non-st-segment-elevation-myocardial-infarction-shortly-after-starting-steroid-replacement-therapy-in-a-patient-with-adrenal-insufficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.25061","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,16]]}}}